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Menthol glucuronide was isolated from the urine of a healthy
70-kg female subject following ingestion of 400 mg of pepper-
mint oil and 6 g of 99% [U-13C]glucose. Glucuronide 13C-excess
enrichment levels were 4–6% and thus provided high signal-
to-noise ratios (SNRs) for conﬁdent assignment of 13C-13C spin-
coupled multiplet components within each 13C resonance by
13C NMR. The [U-13C]glucuronide isotopomer derived via direct
pathway conversion of [U-13C]glucose to [U-13C]UDP-glucose
was resolved from [1,2,3-13C3]- and [1,2-
13C2]glucuronide iso-
topomers derived via Cori cycle or indirect pathway metabolism
of [U-13C]glucose. In a second study, a group of four overnight-
fasted patients (63  10 kg) with severe heart failure were given
peppermint oil and infused with [U-13C]glucose for 4 hr
(14 mg/kg prime, 0.12 mg/kg/min constant infusion) resulting in
a steady-state plasma [U-13C]glucose enrichment of 4.6% 
0.6%. Menthol glucuronide was harvested and glucuronide 13C-
isotopomers were analyzed by 13C NMR. [U-13C]glucuronide
enrichment was 0.6%  0.1%, and the sum of [1,2,3-13C3] and
[1,2-13C2]glucuronide enrichments was 0.9%  0.2%. From
these data, ﬂux of plasma glucose to hepatic UDPG was esti-
mated to be 15%  4% that of endogenous glucose production
(EGP), and the Cori cycle accounted for at least 32%  10% of
GP. Magn Reson Med 56:1121–1125, 2006. © 2006 Wiley-Liss,
Inc.
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The hepatic uridine diphosphate glucose (UDPG) pool is a
strategic site for sampling tracers of human hepatic carbo-
hydrate metabolism (1–4). During feeding, there is net
hepatic glycogen synthesis from both glucose and glu-
coneogenic substrates. Carbon ﬂuxes from these sources
converge at glucose-6-phosphate (G6P) and then pass via
glucose-1-phosphate (G1P) and UDPG pools on the way to
glycogen. Consequently, any 13C-enriched precursor of he-
patic glycogen is also incorporated into UDPG. During
fasting, there is net glucose synthesis from glycogen and
gluconeogenic substrates, and carbon ﬂuxes from these
sources also converge at G6P. While the bulk of G6P is
hydrolyzed to glucose via glucose-6-phosphatase under
these conditions, there is a residual ﬂux from G6P through
the glucose-1-phosphate (G1P) and UDPG pools. Conse-
quently, any 13C-tracer that enriched the hepatic G6P pool
is also incorporated into UDPG. Moreover, the relatively
small pool sizes of hepatic sugar and nucleotide diphos-
phates coupled with extensive G6P-G1P exchange mean
that UDPG and G6P enrichments will be equivalent under
most 13C-tracer study conditions.
In humans, UDPG can be noninvasively sampled by the
administration of drugs such as acetaminophen or diﬂusi-
nal, which are converted into glucuronides and cleared
into urine (4,5). The glucuronide moiety is derived from
hepatic UDPG with no modiﬁcation of the glucose carbon
skeleton or dilution of UDPG 13C-enrichment. Glucuro-
nide appearance in urine is rapid, and pharmacological
doses of acetaminophen or peppermint oil generate 100–
200 mol of urinary glucuronide per hour (10,11). With
this amount of analyte, quantiﬁcation of 13C-isotopomer
populations at 0.1% excess enrichment or less becomes
practical by 13C NMR. In the fed state, acetaminophen
glucuronide enrichment from infused or ingested 13C-glu-
cose provides information on the pathways of hepatic
glycogen synthesis (5–7). In the fasted state, glucuronide
13C-isotopomers from gluconeogenic substrates such as
[U-13C]propionate provides a measure of relative glu-
coneogenic and hepatic Krebs cycle ﬂuxes (8,9).
[U-13C]glucose has also been used as a dual tracer of fast-
ing endogenous glucose production (EGP) and glucose re-
cycling (glucose3pyruvate3glucose) via the Cori and glu-
cose-alanine cycles (12–14). Resolution and quantiﬁcation
of glucose triose 13C-isotopomers formed by the recycling
pathways have been used to estimate the fractional contri-
bution of the Cori cycle and gluconeogenesis to GP (12–
14). However, since the enrichment levels of 13C-isoto-
pomers formed via recycling are typically only 10–20%
that of the infused [U-13C]glucose (15), their precise quan-
tiﬁcation from plasma glucose samples by 13C NMR is
often limited by sample size and the relatively large back-
ground signals from the parent [U-13C]glucose isotopomer.
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Urinary glucuronide provides ﬁve to 10 times more sample
mass than a 20-ml blood glucose sample. Furthermore, the
contribution of the parent [U-13C]glucose tracer to the
glucuronide 13C NMR spectrum is substantially less com-
pared to that of plasma glucose because UDPG synthesis
via the direct pathway is suppressed during fasting.
To date, analysis of acetaminophen glucuronide 13C en-
richment or isotopomer distributions by either mass spec-
trometry (MS) or 13C NMR has required rather laborious
puriﬁcation and derivatization methods (4,16). Recently
we demonstrated that menthol glucuronide derived from
ingestion of peppermint oil can be directly analyzed for 2H
enrichment by 2H NMR following a simple isolation pro-
cedure (11). In this report we demonstrate that direct 13C
NMR spectroscopy of the same menthol glucuronide prep-
aration following administration of [U-13C]glucose and
2H2O tracers provides a wealth of
13C-isotopomer informa-
tion with no interference from the simultaneous incorpo-
ration of 2H into positions 1–5 of glucuronide. Thus, the
direct NMR analysis of menthol glucuronide is a practical
and effective approach for integrating enrichment informa-
tion from 2H and 13C tracers of hepatic carbohydrate me-
tabolism.
MATERIALS AND METHODS
Human Studies
Human studies were performed after the subjects provided
informed consent, and the study protocols were approved
beforehand by the University Hospital of Coimbra Ethics
Committee. In the ﬁrst study, which was designed to gen-
erate high levels of glucuronide 13C-isotopomers for 13C
signal assignments, a healthy 23-year-old female began to
fast at 2130 hr, after she had dinner. She ingested 350 g of
70% 2H2O at 0230 hr the following day, and at 0745 hr she
ingested 2  200 mg enteric-coated peppermint oil cap-
sules and 6 g of 99% [U-13C]glucose. Urine was collected
2–4 hr after the ingestion of peppermint oil. In a second
study, four patients with severe heart failure (NYHA cat-
egory III/IV, weight  63  10 kg) began to fast at 2000 hr.
They ingested 2H2O to 0.5% body water by drinking two
loading doses of 70% 2H2O at 0100 and 0300 hr. At
0600 hr, a 4-hr primed infusion of [U-13C]glucose was
started (14 mg/kg prime, 0.12 mg/kg/min constant infu-
sion), and at 0700 hr, 2  200 mg enteric-coated pepper-
mint oil capsules were ingested. Urine was collected from
0900 to 1100 hr.
Sample Processing
Urine samples were concentrated 10–20-fold to ﬁnal vol-
umes of 15–30 ml by rotary evaporation. The concentrated
urine was then acidiﬁed to pH 1.5 with 6 M HCl. Any
precipitate formed was removed by centrifugation, and a
saturating amount of NaCl was added to the supernatant.
The solution was extracted four to six times with an equal
volume of ether, and the ether fractions were pooled. Ali-
quots containing 100 mol of menthol glucuronide were
evaporated to dryness. A 10-g Discovery DSC-18 SPE car-
tridge was conditioned with 17 ml of methanol and 33 ml
of acidiﬁed water. Acidiﬁed water was prepared by mixing
1 ml of 85% H3PO4 with 700 ml of distilled water. The
menthol glucuronide aliquot was dissolved in 2.5 ml of
water, pH 2.5, and applied to the column. The column was
then washed with 40 ml of acidiﬁed water, followed by
two portions of acidiﬁed water/methanol (80/20% and
50/50%). Menthol glucuronide was eluted with a third
wash of 25/75% acidiﬁed water/methanol. To remove
phosphoric acid, this fraction was evaporated, dissolved
in 2 ml of water (pH 2.5), and applied to a 5-g Discovery
DSC-18 SPE cartridge. The column was washed with 20 ml
of water, and menthol glucuronide was eluted with 40 ml
of 100% methanol. This fraction was evaporated to com-
plete dryness and the residue was dissolved in 0.6 ml of
dry acetonitrile-d3 for
13C NMR analysis.
NMR Spectroscopy
Proton-decoupled 13C NMR spectra were obtained with a
Varian Unity 11.75T system equipped with a 5-mm broad-
band probe. Spectra were obtained with a 60° pulse angle,
an acquisition time of 2.5 s, a spectral width of 25 KHz
(200 ppm), and a pulse delay of 0.5 s. NMR spectra were
analyzed using the curve-ﬁtting routine supplied with the
NUTS PC-based NMR spectral analysis program (Acorn
NMR Inc., Fremont, CA, USA). Menthol glucuronide 13C
chemical shifts were referenced to the methyl carbon of
acetonitrile at 0.3 ppm.
Metabolic Flux Analyses
To demonstrate the application of 13C-isotopomer analysis
of glucuronide for deriving metabolic ﬂux information, we
used menthol glucuronide and plasma glucose 13C-isoto-
pomer distributions to estimate the following ﬂux param-
eters in the group of heart failure patients: Flux from
glucose to UDPG was estimated from the fractional enrich-
ment of menthol [U-13C]glucuronide (Eglucuronide) divided
by the enrichment of the plasma [U-13C]glucose precursor
pool (Eplasma) and multiplied by the endogenous GP rate
(EGP), as shown in the following equation:
Glucose 3 UDPG flux (mol/kg/min)
EGP(Eglucuronide)/(Eplasma) [1]
Cori cycle ﬂux was estimated from the enrichment levels
of “ﬁrst-pass” menthol glucuronide triose isotopomers
(Etriose) relative to the plasma [U-
13C]glucose precursor
pool multiplied by EGP. A correction factor of 1.5 was
used to account for dilution at the level of the oxaloacetate
pool of the hepatic Krebs cycle.1
Cori cycle flux (mol/kg/min)
EGP1.5(Etriose)/(Eplasma) [2]
1Enrichment of any [U-13C]anaplerotic tracer that is converted to glucose via
gluconeogenesis is diluted at the level of oxaloacetate by the oxidative ﬂux of
the Krebs cycle. For the “ﬁrst-pass” isotopomers, this dilution factor is simply
the net anaplerotic ﬂux divided by the sum of anaplerotic plus oxidative
(citrate synthase) ﬂux. Assuming that net anaplerosis is 1.5–3.0 times that of
oxidative ﬂux in humans (8,9,12), the dilution factor ranges from 1.3–1.7.
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RESULTS AND DISCUSSION
Menthol glucuronide derived from urinary ether extracts
and dissolved in acetonitrile at concentrations of 0.2 M
generated narrow and well-resolved 13C resonances for the
six glucuronide carbons. We obtained optimal 13C-signal
linewidths of 0.3–0.5 Hz by acquiring the 13C NMR spec-
trum at 50–70°C. In the single [U-13C]glucose ingestion
study designed to provide high 13C-enrichment levels for
the assignment of glucuronide 13C-isotopomers, the excess
13C-enrichments were 6% for glucuronide carbons 1, 2,
5, and 6, and 4% for carbons 3 and 4. Under these
conditions, most of the individual 13C-isotopomer signals
intensities were comparable to that of the natural abun-
dance 13C signal, and thus allowed conﬁdent identiﬁcation
and assignment.
The 13C-menthol glucuronide signals were also quanti-
ﬁable during a standard isotope-dilution measurement of
fasting EGP with [U-13C]glucose. This substantially en-
hanced the information content of the study and provided
direct insight into ﬂuxes between plasma glucose and he-
patic sugar phosphates. Figure 1 shows a 13C NMR spec-
trum obtained from a heart-failure patient infused with
[U-13C]glucose for 4 hr to a steady-state plasma enrichment
of 5.8% and administered with peppermint oil. The six
glucuronide 13C-resonances consist of singlet signals
(mostly derived from natural-abundance 13C) that are
ﬂanked by 13C-13C-spin-spin coupled multiplets. The mul-
tiplets represent a mixture of glucuronide 13C-isotopomers
derived from hepatic metabolism of [U-13C]glucose (Fig.
2). The presence of long-range 13C-13C couplings that span
the glucuronide triose moieties (e.g., coupling between
carbons 1 and 6) allow the resolution of certain hexose
13C-isotopomer populations. For example, [U-13C]glucu-
ronide generates an eight-line signal in carbon 1 due to a
combination of J1,2, J1,3, and J1,6 coupling (see Table 1 and
Fig. 1). In the [U-13C]glucose infusion experiment, the
probability of forming glucuronide isotopomers contain-
ing 13C in positions 1, 3, and 6 by any pathway other than
conversion of [U-13C]glucose to [U-13C]UDPG by the so-
called “direct pathway” is negligible2. Meanwhile, gluc-
uronide 13C-enrichment patterns arising from the Cori cy-
cle (i.e., metabolism of [U-13C]glucose to the level of pyru-
vate and reincorporation into G6P by gluconeogenesis, as
shown in Fig. 2) consist of triose isotopomers, such as
[1,2,3-13C3]glucuronide. Such isotopomer populations are
well resolved in the 13C NMR spectrum of menthol gluc-
uronide because the J1,2 and J2,3 coupling constants have
different magnitudes, hence [1,2-13C2], [2,3-
13C2] and
[1,2,3-13C3]glucuronide isotopomers generate distinctive
13C NMR splitting patterns within the carbon 2 resonance.
Likewise, different J4,5 and J5,6 coupling constants mean
that the carbon 5 resonance has fully resolved multiplet
signals for [4,5-13C2], [5,6-
13C2] and [4,5,6-
13C3]glucuronide
isotopomers. Hence, all possible triose isotopomers that are
generated by the metabolism of [U-13C]glucose through the
Cori cycle are detectable. 13C-Enriched gluconeogenic sub-
strates, such as [U-13C]propionate, generate the same set of
triose 13C-isotopomers, and their relative abundance pro-
vides information on anaplerotic and pyruvate recycling
ﬂuxes of the hepatic Krebs cycle (8,9,17). In this setting,
the menthol glucuronide 13C NMR spectrum will provide
well-resolved multiplets in both carbon 2 and 5 reso-
nances, allowing reliable quantiﬁcation of the triose 13C-
isotopomer population. Although it was beyond the scope
of this study, the complete resolution of menthol glucuro-
nide 1H signals (11) facilitates the quantiﬁcation of gluc-
uronide 13C-isotopomer distributions by alternative indi-
rect detection techniques such as J-resolved heteronuclear
single quantum coherence (JHSQC) and heteronuclear
multiple quantum coherence total correlation spectros-
copy (HMQC-TOCSY) (18–20).
2In this experimental setting, the probability of synthesizing G6P with two
labeled triose moieties via gluconeogenesis or an indirect pathway is very low.
FIG. 1. 13C NMR spectrum of puriﬁed men-
thol glucuronide obtained from urine col-
lected after ingestion of peppermint oil and
infusion of [U-13C]glucose. The multiplets of
carbons 1 and 2 are shown in expanded
form and with a ﬁvefold vertical gain. As-
signments of individual 13C-isotopomer
components and estimated enrichment lev-
els of selected 13C-hexose and triose isoto-
pomers are also shown.
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In the four heart-failure patients studied, the enrichment
of [U-13C]glucuronide was estimated to be 0.6%  0.1%.
Plasma [U-13C]glucose enrichment was 4.6%  0.6%, and
EGP was estimated to be 14.7  1.6 mol/kg/min (data not
shown). From the ratio of [U-13C]glucuronide to [U-13C]glu-
cose enrichment (see Eq. [1]), the ﬂux of glucose to UDPG
was estimated at 2.3  1.5 mol/kg/min corresponding to
15%  4% of GP. These data indicate that conversion of
plasma glucose to UDPG occurs even during fasting, when
the liver is a net exporter of glucose. These estimates are
somewhat higher than that reported in a study of over-
night-fasted healthy humans by Hellerstein et al. (5), in
which the glucose to UDPG ﬂux was estimated to be about
8% of GP.
The enrichment levels of glucuronide triose isotopomers
are sensitive to the extent of glucose recycling via the Cori
and glucose-alanine cycles. Infused [U-13C]glucose is ini-
tially metabolized to [U-13C]pyruvate via glycolysis in pe-
ripheral tissues. Subsequently, this product is exported to
the liver as [U-13C]lactate or alanine, and incorporated into
the gluconeogenic pathway following conversion to
[U-13C]pyruvate, carboxylation to OAA via pyruvate car-
boxylase, and conversion to PEP via PEP-carboxykinase.
Due to exchanges at the level of the Krebs cycle, anaple-
rotic entry of [U-13C]pyruvate will generate eight different
PEP 13C-isotopomers, as shown in Fig. 2. Of these,
[U-13C]PEP and [2,3-13C2]PEP are derived by “ﬁrst-pass”
metabolism of the [U-13C]pyruvate carbon skeleton
through the hepatic OAA pool, and these two isotopomers
become [1,2,3-13C3] and [1,2-
13C2]glucuronide
3. Quantiﬁ-
cation of these isotopomer enrichments relative to that of
the plasma [U-13C]glucose precursor provides an estimate
of the Cori cycle ﬂux (see Eq. [2]). For the heart-failure
patients, the summed enrichment of [1,2,3-13C3] and [1,2-
13C2]glucuronide was 0.9%  0.1%. From these and the
plasma glucose isotopomer data, Cori cycle ﬂux was cal-
culated to be 5.0 2.1 mol/kg/min corresponding to 32%
 10% of GP. While this value is high compared to esti-
mates of 15–20% obtained by NMR and GC-MS analyses
of plasma glucose isotopomers following [U-13C]glucose
infusion in overnight-fasted healthy subjects (12,14,15), it
is similar to the value of 36% reported for healthy subjects
fasted for 40 hr (12) and the estimate of 33% for cancer
patients with high serum cortisol levels (13). Hence, Cori
cycling is elevated when hepatic glycogen stores are de-
pleted by prolonged fasting, or during hypermetabolic
conditions as indicated by high cortisol levels. Our ﬁnding
of comparably high levels of Cori cycle ﬂux in the heart-
failure patients is consistent with a growing consensus
3An equivalent amount of [4,5,6-13C3] and [5,6-
13C3]
13C2]glucuronide isoto-
pomers will also be produced.
FIG. 2. Formation of oxaloacetate
(OAA), phosphoenolpyruvate (PEP)
and UDP-glucose (UDPG) 13C-iso-
topomers during metabolism of
[U-13C]glucose via the indirect
pathway and hepatic Krebs cycle.
For clarity, only triose isoto-
pomers from one half of the
UDPG molecule (i.e., carbons 1,
2, and 3) are shown. Isotopomer a
is formed by carboxylation of
[1,2,3-13C3]pyruvate. OAA-fumar-
ate randomization converts up to
50% of this population to isoto-
pomer b. Pyruvate recycling in
combination with OAA-fumarate
randomization generates isoto-
pomer c from both a and b (17).
Isotopomers d–i are derived from
13C-enriched OAA that is metab-
olized to citrate and regenerated
via the oxidative span of the
Krebs cycle.
Table 1
Chemical Shifts and 13C-13C Coupling Constants for the Glucuronide Moiety of Menthol Glucuronide
Glucuronide position 1 2 3 4 5 6
13C Chemical shift (ppm) 100.26 73.49 76.39 71.87 74.61 169.61
13C-13C one-bond coupling constants (Hz) 1JC1-C2 47.6
1JC2-C1 47.6
1JC3-C2 39.5
1JC4-C3 39.3
1JC5-C4 39.6
1JC6-C5 64.5
1JC2-C3 39.5
1JC3-C4 39.3
1JC4-C5 39.6
1JC5-C6 64.5
13C-13C multiple bond coupling constants (Hz) 2JC1-C3 4.7
2JC2-C4 2.4
2JC3-C1 4.7
2JC4-C2 2.4
2JC5-C3 2.8
3JC6-C1 5.5
3JC1-C6 5.5
2JC3-C5 2.8
2JC4-C6 0.8
2JC6-C4 0.8
3JC3-C6 5.1
3JC6-C3 5.1
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that severe heart failure is associated with insulin resis-
tance and hypermetabolism (21).
In conclusion, our studies demonstrate that a wealth of
13C-isotopomer information describing human hepatic
[U-13C]glucose metabolism can be resolved in a simple
manner by direct 13C NMR analysis of urinary menthol
glucuronide. This approach can be applied to other 13C-
tracers of hepatic gluconeogenesis and glycogen synthesis.
The 13C NMR measurement can accommodate and com-
plement isotopic enrichment and metabolic information
from 2H-enriched tracers of human glucose metabolism,
thereby facilitating the design of highly informative non-
invasive tracer assays of hepatic glucose and glycogen
metabolism.
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